window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 13, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

AI in clinical trials

  • Clinical & Regulatory,Digital & Data

    Transitioning to risk-based clinical trial management under ICH E6(R3)

    Risk-based quality management (RBQM) is becoming central to clinical trial [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain

    PSI launches AI platform to improve clinical trial site selection and enrolment

    PSI CRO has launched SYNETIC, an AI-powered semantic knowledge platform [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Pharmaceuticals and therapeutics

    CluePoints names Sinead Godkin CPO to scale global workforce

    CluePoints has appointed Sinead Godkin as chief people officer, strengthening [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    CluePoints: how proactive oversight and AI are reshaping clinical trial data management

    Dan Beaudry, market owner for risk-based quality management (RBQM) at [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Medable launches AI agent to automate trial master file workflows

    Medable has launched a new artificial intelligence-powered agent designed to [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events

    Nine ladies dancing: uMotif – patient-centric trials and AI take centre stage in 2026

    As part of Discover Pharma’s 12 days of Christmas series, [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    AI in research and clinical trials: Speed, accuracy, and a smarter future

    AI is rapidly transforming how clinical trials are designed, run, [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events

    Phesi CEO warns of looming Phase 3 trial failures as sponsors overlook real-world data and overcrowd sites

    New analysis reveals billions risked on overly complex trials that [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data

    Advarra launches industry council to guide responsible AI use in clinical trials

    A new industry council aims to shape best practices for [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    RBQMLive returns in 2025 with agenda on regulation, ROI and AI in clinical trials

    CluePoints releases full speaker lineup for free virtual event focused [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • FDA issues Complete Response Letter for ITM-11 over manufacturing issues
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics
  • Grifols completes Phase 3 SPARTA study of Prolastin-C in alpha-1 emphysema
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
  • Novo Nordisk and AWS launch London AI hub to accelerate drug discovery
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top